July 11, 2020
San Quentin prison in US has seven deaths and 1,500 positive tests; Serbia has record 18 fatalities; Australia caps incoming flights and charges for quarantine
Australia’s drugs regulator, the Therapeutic Goods Administration [TGA], has granted provisional approval for the drug remdesivir to be used as the first treatment option for Covid-19. It has received provisional approval for use in adults and adolescent patients with severe Covid-19 symptoms in hospital.
“Remdesivir is the most promising treatment option so far to reduce hospitalisation time for those suffering from severe coronavirus infections,” the TGA said. “Remdesivir offers the potential to reduce the strain on Australia’s health care system. By reducing recovery times patients will be able to leave hospital earlier, freeing beds for those in need. Remdesivir will not be available to Australians unless they are severely unwell, requiring oxygen or high level support to breathe, and in hospital care.”
Coronavirus cases are rising across the US, some regional hospitals are filling up and some of America’s most populous places are seeing record deaths as the pandemic surges.
At the same time, as some states reverse reopening plans, public health interventions such as encouraging people to wear public face coverings and closing schools have become increasingly politicised and divisive.
Related: Over 40 Florida hospitals max out ICU capacity as Covid-19 cases surge across US